You are here
AusPAR: Regdanvimab
Related information
Australian Public Assessment Report
7 December 2021
| AusPAR | |
|---|---|
| Active Ingredient | Regdanvimab
|
| Product Name | Regkirona
|
| Sponsor | Celltrion Healthcare Australia Pty Ltd
|
| Submission Number | PM-2021-04004-1-2
|
| Submission Type | New biological entity
|
| Decision | Approved for provisional registration
|
| AusPAR Date | 6 December 2021
|
| Publication Date | 7 December 2021 |